Jan van Meerbeeck
0000-0001-7872-8622
196 papers found
Refreshing results…
Exhaled breath to screen for malignant pleural mesothelioma: a validation study
Evaluation of the solitary pulmonary nodule: size matters, but do not ignore the power of morphology
Patient-reported outcome measures (PROMs) in the management of lung cancer: A systematic review
Treatment recommendations by clinicians in stage I non-small cell lung cancer: better work-up leads to less discussion
Wolf in Sheep’s Clothing: Primary Lung Cancer Mimicking Benign Entities
Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma: a cross-sectional case-control study
Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients
LUME-Meso: Design and Rationale of the Phase III Part of a Placebo-Controlled Study of Nintedanib and Pemetrexed/Cisplatin Followed by Maintenance Nintedanib in Patients With Unresectable Malignant Pleural Mesothelioma
Patterns of care for non-small cell lung cancer patients in Belgium: A population-based study
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial
Addressing the Palliative Setting in Advanced Lung Cancer Should Not Remain a Barrier: A Multicenter Study
The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer
Recurrent dysphasia due to nivolumab-induced encephalopathy with presence of Hu autoantibody
Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients
O 6 -Methylguanine-DNA methyltransferase (MGMT): A drugable target in lung cancer?
Malignant pleural mesothelioma: single-institution experience of 101 patients over a 15-year period
Rare cause of dyspnoea,Zeldzame oorzaak van dyspneu
The IASLC mesothelioma staging project: improving staging of a rare disease through international participation
The IASLC mesothelioma staging project: proposals for the m descriptors and for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for mesothelioma
Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma
Missing publications? Search for publications with a matching author name.